Literature DB >> 27829349

Cytotoxicity of Silver Nanoparticles Against Bacteria and Tumor Cells.

Tianyuan Shi1, Xuesong Sun1, Qing-Yu He1.   

Abstract

With the rapid increase of multiple drug-resistant bacteria, silver nanoparticles (AgNPs) with broad-spectrum antibacterial activities have been widely applied in the treatment of bacterial infection. Meanwhile, AgNPs also have anticancer activities against different cell lines. The toxic effects of AgNPs depend on concentration, size, shape, coated materials and surrounding environments. In order to better understand the antibacterial and antitumor effects of AgNPs, various investigations have been carried out to uncover the molecular mechanism of action. This review summarizes the recent studies on the action mechanisms of AgNPs related to their antibacterial activities including collapsing cell walls, inducing reactive oxygen species, inhibiting aerobic respiration and damaging DNA and their antitumor effects including impairing mitochondria, blocking cell cycle, and activating apoptosis. In these investigations, the systematic approaches have not been extensively applied. Increasingly matured omics techniques including genomics, transcriptomic, translatomics and proteomics should be more widely explored to provide the comprehensive views of the cytotoxic effects of AgNPs to bacteria and tumor cells and thus globally illustrate the molecular mechanisms of the cytotoxicity, promoting the better medical application of AgNPs in the future. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Silver nanoparticles; antibacteria; anticancer; cytotoxicity; drug resistance; tumor cells.

Mesh:

Substances:

Year:  2018        PMID: 27829349     DOI: 10.2174/1389203718666161108092149

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  7 in total

1.  Biogenic Silver Nanoparticles Strategically Combined With Origanum vulgare Derivatives: Antibacterial Mechanism of Action and Effect on Multidrug-Resistant Strains.

Authors:  Sara Scandorieiro; Bianca C D Rodrigues; Erick K Nishio; Luciano A Panagio; Admilton G de Oliveira; Nelson Durán; Gerson Nakazato; Renata K T Kobayashi
Journal:  Front Microbiol       Date:  2022-05-06       Impact factor: 6.064

2.  Facile synthesis of 1.3 nm monodispersed Ag nanoclusters in an aqueous solution and their antibacterial activities for E. coli.

Authors:  Chengpeng Jiao; Yuantao Pei; Liqiong Wang; Haijun Zhang; Zili Huang; Yuhuan Dai; Feng Liang; Simin Liu; Yuhua Wang; Shaowei Zhang
Journal:  RSC Adv       Date:  2018-08-28       Impact factor: 4.036

3.  Size-dependent cytotoxicity of silver nanoparticles to Azotobacter vinelandii: Growth inhibition, cell injury, oxidative stress and internalization.

Authors:  Li Zhang; Lingli Wu; Youbin Si; Kunhui Shu
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

4.  Photocatalytic Protein Damage by Silver Nanoparticles Circumvents Bacterial Stress Response and Multidrug Resistance.

Authors:  Tianyuan Shi; Qiuxia Wei; Gong Zhang; Xuesong Sun; Qing-Yu He; Zhen Wang
Journal:  mSphere       Date:  2019-05-01       Impact factor: 4.389

5.  Antiproliferative and Antitumour Effect of Nongenotoxic Silver Nanoparticles on Melanoma Models.

Authors:  Lucía M Valenzuela-Salas; Nayeli G Girón-Vázquez; Juan C García-Ramos; Olivia Torres-Bugarín; Claudia Gómez; Alexey Pestryakov; Luis J Villarreal-Gómez; Yanis Toledano-Magaña; Nina Bogdanchikova
Journal:  Oxid Med Cell Longev       Date:  2019-07-25       Impact factor: 6.543

Review 6.  Nanocarrier-mediated antioxidant delivery for liver diseases.

Authors:  Senlin Li; Huiru Li; Xiaoding Xu; Phei Er Saw; Lei Zhang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

7.  Application potential of biogenically synthesized silver nanoparticles using Lythrum salicaria L. extracts as pharmaceuticals and catalysts for organic pollutant degradation.

Authors:  Nikola Z Srećković; Zoran P Nedić; Davide Liberti; Daria Maria Monti; Nevena R Mihailović; Jelena S Katanić Stanković; Silvana Dimitrijević; Vladimir B Mihailović
Journal:  RSC Adv       Date:  2021-11-03       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.